# [Corrected]
**AGENCY:**
Food and Drug Administration, HHS.
**ACTION:**
Final rule; correction.
**SUMMARY:**
The Food and Drug Administration (FDA) is correcting a document amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) that appeared in the *Federal Register* of June 19, 2003 (68 FR 36744). FDA is correcting the amount of monocalcium phosphate in the formula for a free-choice, loose mineral Type C medicated feed containing lasalocid that was entered inaccurately. This correction is being made so the lasalocid regulations accurately reflect the approved formula.
**DATES:**
This rule is effective June 19, 2003.
**FOR FURTHER INFORMATION CONTACT:**
George K. Haibel, Center for Veterinary Medicine (HFV-6), Food and Drug Administration, 7519 Standish Pl., Rockville, MD 20855, 301-827-4567, e-mail: *[email protected]* .
**SUPPLEMENTARY INFORMATION:**
In FR Doc. 03-15541, published on June 19, 2003 (68 FR 36744), the following correction is made:
**21 CFR Part 558**
§ 558.311
On page 36745, in the first column, in the table in § 558.311 *Lasalocid* in paragraph (e)(4)(i), in the row for “Monocalcium Phosphate” the entry in the “Percent” column is corrected to read “57.70”.
Dated: August 7, 2003.
David R. Newkirk,
Acting Director, Office of New Animal Drug Evaluation, Center for Veterinary Medicine.